General Western Blot Reagents
Abcam Bezafibrate, Pan-PPAR agonist, 5G
MW 361.8 Da, Purity >99%. Pan-PPAR agonist (EC₅₀ values are 50, 60 and 20 μM at PPARα, PPARγ and PPARδ human receptors respectively). More efficient than fenofibrate (ab120832) in reducing body weight and blood glucose. Antidiabetic and antihyperlipidemic effects.
The product is subject to the following: Abcam Restricted Use Statement
![Abcam Anti-FOXA1 antibody [RM1119] - BSA and Azide free.](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502711400.JPG-250.jpg)
Abcam Anti-FOXA1 antibody [RM1119] - BSA and Azide free.
Anti-FOXA1 antibody [RM1119] - BSA and Azide free.
The product is subject to the following: Abcam Restricted Use Statement
Abcam D-Fructose 1,6-diphosphate trisodium salt, Common metabolic sugar, 5G
MW 406.06 g/mol, Purity >98%. Common metabolic sugar. Precursor of glyceraldehyde 3-phosphate and dihydroxyacetone phosphate in the glycolytic pathway. Allosteric activator of enzymes such as pyruvate kinase and NAD+-dependent L-(+)-lactate dehydrogenase. Inhibitor of acetate kinase. Used as a substrate to identify and characterize enzymes such as fructose-1,6-bisphosphate aldolase(s) and fructose-1,6-bisphosphatase(s).
The product is subject to the following: Abcam Restricted Use Statement
Abcam BU 224 hydrochloride, Imidazoline I2 binding site allosteric modulator, 50MG
MW 233.69 Da, Purity >99%. High affinity Imidazoline I2 binding site allosteric modulator (Ki = 2.1 nM). Dose-dependently inhibits C-fiber evoked responses, post-discharge and wind-up. Shows antinociceptive effects *in vivo.*.
The product is subject to the following: Abcam Restricted Use Statement
![OriGene Cytochrome P450 2E1 (CYP2E1) Mouse Monoclonal Antibody [Clone ID: OTI9E6]](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502542822.JPG-250.jpg)
OriGene Cytochrome P450 2E1 (CYP2E1) Mouse Monoclonal Antibody [Clone ID: OTI9E6]
Cytochrome P450 2E1 (CYP2E1) Mouse Monoclonal Antibody [Clone ID: OTI9E6]
Abcam 640/660 nm E x tracellular Vesicle Membrane Staining Kit, 100 TestsS
Labeling in < 4 hrs with 30 secs hands-on time using 640/660 nm Extracellular Vesicle Membrane Staining Kit ab314688. 100% antibody recovery.
The product is subject to the following: Abcam Restricted Use Statement
![Abcam Anti-NLRP3 antibody [RM1021] - BSA and Azide free.](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502669000.JPG-250.jpg)
Abcam Anti-NLRP3 antibody [RM1021] - BSA and Azide free.
Anti-NLRP3 antibody [RM1021] - BSA and Azide free.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Malate Dehydrogenase 2 (MDH2) Activity Assay
Malate Dehydrogenase 2 (MDH2) Activity Assay
The product is subject to the following: Abcam Restricted Use Statement
Abcam Anti Cd47 Antibody Rm1014 AB284132-1ML
Anti Cd47 Antibody Rm1014 AB284132-1ML
The product is subject to the following: Abcam Restricted Use Statement
Abcam BTBCT, Europium beta-diketone chelate, 250MG
MW 604.9 Da, Purity >95%. Europium β-diketone chelate. Provides 8 times improved detection sensitivity compared to BHHCT-(Asc5314
The product is subject to the following: Abcam Restricted Use Statement
Abcam YM-01 (YM-1), allosteric Hsp70 modulator, 25MG
MW 417.97 g/mol, Purity >98%. Allosteric Hsp70 modulator. Potent anti-tau agent. MKT-077 analog. Promotes triage functions of Hsp70. Rapidly and potently reduces tau levels ex vivo. Shows antitumor effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Zinpyr-1, Fluorogenic Zn2+ reporter, 125MG
MW 823.72 g/mol, Purity >95%. Cell-permeable fluorogenic Zn²+ reporter. 2,7-Dichlorofluorescein (ab146332) derivative. Induces positive fluorescence upon metal ion complexation. PET sensor.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 271046 hydrochloride, 5-HT6 antagonist, 50MG
MW 488.45 g/mol, Purity >99%. Potent and selective 5-HT₆ receptor antagonist (Ki = 1-2 nM). Displays >200-fold selectivity for 5-HT₆ receptors (vs. other receptor binding sites and ion channels). Poor penetration of the blood-brain barrier. Nootropic effects in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam PRIMA-1MET, p53 activity, 10MG
MW 199.25 Da, Purity >98%. Methylated derivative of PRIMA-1 (ab141641). Restores wild-type conformation and function to mutant p53, and triggers apoptosis in tumor cells. Acts synergistically with chemotherapeutic agents to inhibit tumor cell proliferation. Inhibits thioredoxin reductase 1 (TrxR1), a key regulator of cellular redox balance.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Methyl 3-hydro x yoctanoate, 3-Hydro x yoctanoic acid derivative, 25MG
MW 174.24 Da, Purity >98%. 3-Hydroxyoctanoic acid (ab144042) derivative. Polyester. Medium-chain-length 3-hydroxyalkanoate.
The product is subject to the following: Abcam Restricted Use Statement